Clinical Trial Update: Essential Amino Acids and Parkinsons Disease [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial investigating essential amino acids for Parkinson disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: University of Arkansas | Conditions: Parkinson Disease | Phase 1 | Status: WITHDRAWN